Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia.
We describe clinical experiences in the management of three patients with laryngopharyngeal dystonia causing severe breathing problems. In contrast to spasmodic dysphonia, which presents with action-induced involuntary spasm of laryngeal muscles during speaking, all three patients showed laryngopharyngeal spasms primarily during respiration. In analogy to spasmodic dysphonia we propose the term spasmodic laryngeal dyspnea for this rare condition. Localized unilateral botulinum toxin injected into the thyroarytenoid muscle and/or ventricular folds reduced the quantity and quality of spasms and led to a pronounced improvement of breathing problems.
Zwirner
P
P
Abt. Phoniatrie und Pädaudiologie, Georg-August-Universität Göttingen, Germany.
Dressler
D
D
Kruse
E
E
D000368:Aged; D001905:Botulinum Toxins / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004417:Dyspnea / Q000188:drug therapy / Q000209:etiology*; D004421:Dystonia / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007818:Laryngeal Diseases / Q000175:diagnosis* / Q000188:drug therapy; D007826:Laryngismus / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged
D001905:Botulinum Toxins